Literature DB >> 24843243

Extramedullary pulmonary hematopoiesis causing pulmonary hypertension and severe tricuspid regurgitation detected by technetium-99m sulfur colloid bone marrow scan and single-photon emission computed tomography/CT.

Syed Zama Ali1, Michael John Clarke1, Anbalagan Kannivelu1, Dinesh Chinchure1, Sivasubramanian Srinivasan1.   

Abstract

Extramedullary pulmonary hematopoiesis is a rare entity with a limited number of case reports in the available literature only. We report the case of a 66-year-old man with known primary myelofibrosis, in whom a Technetium-99m sulfur colloid bone marrow scan with single-photon emission computed tomography (SPECT)/CT revealed a pulmonary hematopoiesis as the cause of pulmonary hypertension and severe tricuspid regurgitation. To the best of our knowledge, this is the first description of Technetium-99m sulfur colloid SPECT/CT imaging in this rare condition.

Entities:  

Keywords:  Extramedullary pulmonary hematopoiesis; Pulmonary hypertension; SPECT/CT; Technetium-99m sulfur colloid bone marrow scan; Tricuspid regurgitation

Mesh:

Substances:

Year:  2014        PMID: 24843243      PMCID: PMC4023057          DOI: 10.3348/kjr.2014.15.3.376

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  8 in total

1.  Typical and atypical presentations of extramedullary hemopoiesis.

Authors:  Christos S Georgiades; Edward G Neyman; Isaac R Francis; Michael B Sneider; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

2.  A 62-year-old woman with dyspnea, leukocytosis, and diffuse ground-glass opacities.

Authors:  Abubakr A Bajwa; Faisal Usman; David Wolfson; Luis F Laos; James D Cury
Journal:  Chest       Date:  2010-06       Impact factor: 9.410

3.  A 71-year-old woman with myelofibrosis, hypoxemia, and pulmonary hypertension.

Authors:  Terence K Trow; A Christina Argento; Ami N Rubinowitz; Roy Decker
Journal:  Chest       Date:  2010-12       Impact factor: 9.410

4.  Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia.

Authors:  Elisa Rumi; Francesco Passamonti; Emanuela Boveri; Mara De Amici; Cesare Astori; Marta Braschi; Carlo Castagnola; Umberto Magrini; Mario Cazzola; Mario Lazzarino
Journal:  Am J Hematol       Date:  2006-02       Impact factor: 10.047

5.  Increased lung uptake on technetium-99m-sulfur colloid liver-spleen scans in patients with hepatic venoocclusive disease following bone marrow transplantation.

Authors:  A F Jacobson; M A Marks; W D Kaplan
Journal:  J Nucl Med       Date:  1990-03       Impact factor: 10.057

6.  Unexplained pulmonary hypertension in chronic myeloproliferative disorders.

Authors:  D Dingli; J P Utz; M J Krowka; A L Oberg; A Tefferi
Journal:  Chest       Date:  2001-09       Impact factor: 9.410

7.  A 62-year-old woman with bilateral pleural effusions and pulmonary infiltrates caused by extramedullary hematopoiesis.

Authors:  C Schwarz; R Bittner; A Kirsch; C Loddenkemper; T Mairinger; N Schonfeld; M Serke; R Loddenkemper
Journal:  Respiration       Date:  2008-08-04       Impact factor: 3.580

8.  Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.

Authors:  G García-Manero; S J Schuster; H Patrick; J Martinez
Journal:  Am J Hematol       Date:  1999-02       Impact factor: 10.047

  8 in total
  2 in total

1.  Paravertebral pseudotumor in patient with hereditary spherocytosis.

Authors:  Lêda Maria Rabelo; Vítor Lopes Galvão Vieira; Gustavo Rengel Dos Santos; Giselle Heimbecker; Dante Luiz Escuissato
Journal:  Respir Med Case Rep       Date:  2016-07-27

2.  Assessment of sites of marrow and extramedullary hematopoiesis by hybrid imaging in primary myelofibrosis patients.

Authors:  Mario Ojeda-Uribe; Olivier Morel; Constantin Ungureanu; Christophe Desterke; Marie-Caroline Le Bousse-Kerdilès; Hatem Boulahdour
Journal:  Cancer Med       Date:  2016-08-12       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.